Tirzepatide 30 MG

### Dual Incretin Receptor Co-Agonist for Metabolic Research

Tirzepatide (30 MG) is a synthetic 39-amino acid peptide formulated as a biased dual agonist for human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Modified with a C20 diacid fatty acid moiety that provides enhanced biological half-life and albumin binding. Synthesized to high purity (?99.0%) and lyophilized under sterile inert argon atmosphere.

### Research Scope

• **Dual Receptor Engagement**: Synergistic co-activation of GIPR and GLP-1R in pancreatic beta-cell models.

• **Insulinotropic Kinetics**: Assessment of glucose-dependent insulin secretion pathways.

• **Adipose Metabolism**: Investigates lipid uptake, lipolysis inhibition, and adiponectin release in vitro.

### Specifications

• **Amino Acid Count**: 39 amino acids

• **Molecular Formula**: C225H348N48O68

• **Molecular Weight**: ~4813.5 g/mol

• **Purity**: ?99.0% (RP-HPLC certified)

• **Endotoxin**: <0.5 EU/mg

### Handling & Storage

• Store lyophilized powder at -20??C.

• Reconstitute using 2-3 mL sterile Bacteriostatic Water. Maintain at 2??C to 8??C. Protect from vigorous agitation.